Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37.4M
-
Number of holders
-
88
-
Total 13F shares, excl. options
-
25.9M
-
Shares change
-
-9.8K
-
Total reported value, excl. options
-
$306M
-
Value change
-
-$563K
-
Number of buys
-
33
-
Number of sells
-
-34
-
Price
-
$11.84
Significant Holders of LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) as of Q4 2018
97 filings reported holding LFCR - LIFECORE BIOMEDICAL, INC. DE - Common Stock as of Q4 2018.
LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) has 88 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25.9M shares
of 37.4M outstanding shares and own 69.14% of the company stock.
Largest 10 shareholders include NWQ Investment Management Company, LLC (3.64M shares), FRANKLIN RESOURCES INC (2.72M shares), WYNNEFIELD CAPITAL INC (2.68M shares), DIMENSIONAL FUND ADVISORS LP (2.33M shares), BlackRock Inc. (2.05M shares), Vanguard Group Inc (1.6M shares), ROYCE & ASSOCIATES LP (1.43M shares), HEARTLAND ADVISORS INC (838K shares), INVESTMENT COUNSELORS OF MARYLAND LLC (798K shares), and Walthausen & Co., LLC (728K shares).
This table shows the top 88 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.